Literature DB >> 21277617

Encrusting cystitis due to Corynebacterium urealyticum in a patient with ANCA-associated vasculitis: case report and review of the literature.

Christian Pagnoux1, Alice Bérezné, Richard Damade, Jacques Paillot, Jessie Aouizerate, Véronique Le Guern, Dominique Salmon, Loïc Guillevin.   

Abstract

OBJECTIVES: To report a patient with systemic ANCA-associated vasculitis, under maintenance treatment, who had persistent microscopic hematuria and developed recurrent pelvic pain due to Corynebacterium urealyticum encrusting cystitis. The relevant literature on this infection is reviewed.
METHODS: Descriptive case report and a review of the literature (PubMed search).
RESULTS: A 39-year-old woman on maintenance therapy for systemic ANCA-associated vasculitis, diagnosed 10 months earlier and with persistent microscopic hematuria, developed recurrent pelvic pain. She had received several immunosuppressants (including cyclophosphamide and rituximab) since the onset of her vasculitis, as well as cycles of broad-spectrum antibiotics during the acute initial phase of her disease. Computerized tomography of the pelvis and cystoscopy showed several encrusted calcifications in the bladder mucosa, and, finally, urine culture (selective media) led to the diagnosis of C. urealyticum infection. Most of the bladder-encrusted stones were removed during cystoscopy and daily intramuscular teicoplanin injections were given for 14 days. Her symptoms disappeared rapidly and completely. On reviewing the literature, immunosuppression, previous broad-spectrum antibiotics, urogenital alkaline pH, and prolonged bladder catheterization are predisposing factors for this rare infection. C. urealyticum encrusting cystitis has been reported in patients with systemic diseases but not yet in ANCA-associated vasculitis. Outcome is almost always good under adequate antibiotic therapy, mainly glycopeptides.
CONCLUSION: Physicians should be aware of this unusual but potentially emerging infectious complication that can be challenging in ANCA-associated vasculitis, because the urinary tract can be affected by the vasculitis or as a complication of previous cyclophosphamide therapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21277617     DOI: 10.1016/j.semarthrit.2010.11.004

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  5 in total

Review 1.  Nephrolithiasis by Corynebacterium urealyticum infection: literature review and case report.

Authors:  Laura Cappuccino; Paolo Bottino; Adele Torricella; Roberto Pontremoli
Journal:  J Nephrol       Date:  2014-02-22       Impact factor: 3.902

2.  Successful treatment of Corynebacterium urealyticum encrusting cystitis with systemic and intravesical antimicrobial therapy.

Authors:  Oriana Raab; Romain Béraud; Karen M Tefft; C Anne Muckle
Journal:  Can Vet J       Date:  2015-05       Impact factor: 1.008

Review 3.  Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract.

Authors:  Kimberly A Kline; Amanda L Lewis
Journal:  Microbiol Spectr       Date:  2016-04

Review 4.  Corynebacterium urealyticum: a comprehensive review of an understated organism.

Authors:  Nagla Salem; Lamyaa Salem; Sally Saber; Ghada Ismail; Martin H Bluth
Journal:  Infect Drug Resist       Date:  2015-05-21       Impact factor: 4.003

5.  The importance of surgical treatment in encrusted cystitis and pyelitis: A case report.

Authors:  Ahmed Loghmari; Khaireddine Bouassida; Oussama Belkacem; Mouna Ben Othmane; Wissem Hmida; Mehdi Jaidane
Journal:  Int J Surg Case Rep       Date:  2020-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.